PAO Group Inc (PAOG)

[Stock Caller]

If you look at the CEO, who sold his last company for $540 million and realize this is a CBD BIOPHARMA company with massive upside to be gained, not to mention looking at how quickly they’ve risen in share price in just a few months, you’d have to be blind to not be able see that this thing is set to take off. Once they get the new drug use approval for Covid-19 & COPD treatments, not to mention they’ll be able to get approval to use on ARDS eventually, and they start treating people with respiratory illnesses this stock could go dollars very easily or they could be acquired by an even bigger cannabis or biopharma company resulting in share holders making a lot with a cash buyout. Once this stock clears a penny it’ll never be able to be purchased again under $.0040. Better stock up now folks because by Halloween this thing is going to start climbing and that’s all she wrote. Shorters are going to get smoked and the investors who hold long-term will be wealthy. In a couple of years, if it hasn’t been acquired yet, share price will easily be $3. In the future all that will be said is “I tried to tell you.”